Literature DB >> 27166089

Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.

Tihomir Miralem1, Nicole Lerner-Marmarosh1, Peter E M Gibbs1, Jermaine L Jenkins1, Chelsea Heimiller1, Mahin D Maines2.   

Abstract

Biliverdin reductase A (BVR) and Akt isozymes have overlapping pleiotropic functions in the insulin/PI3K/MAPK pathway. Human BVR (hBVR) also reduces the hemeoxygenase activity product biliverdin to bilirubin and is directly activated by insulin receptor kinase (IRK). Akt isoenzymes (Akt1-3) are downstream of IRK and are activated by phosphatidylinositol-dependent kinase 1 (PDK1) phosphorylating T(308) before S(473) autophosphorylation. Akt (RxRxxSF) and PDK1 (RFxFPxFS) binding motifs are present in hBVR. Phosphorylation of glycogen synthase kinase 3 (GSK3) isoforms α/β by Akts inhibits their activity; nonphosphorylated GSK3β inhibits activation of various genes. We examined the role of hBVR in PDK1/Akt1/GSK3 signaling and Akt1 in hBVR phosphorylation. hBVR activates phosphorylation of Akt1 at S(473) independent of hBVR's kinase competency. hBVR and Akt1 coimmunoprecipitated, and in-cell Förster resonance energy transfer (FRET) and glutathione S-transferase pulldown analyses identified Akt1 pleckstrin homology domain as the interactive domain. hBVR activates phosphorylation of Akt1 at S(473) independent of hBVR's kinase competency. Site-directed mutagenesis, mass spectrometry, and kinetic analyses identified S(230) in hBVR (225)RNRYLSF sequence as the Akt1 target. Underlined amino acids are the essential residues of the signaling motifs. In cells, hBVR-activated Akt1 increased both GSK3α/β and forkhead box of the O class transcription class 3 (FoxO3) phosphorylation and inhibited total GSK3 activity; depletion of hBVR released inhibition and stimulated glucose uptake. Immunoprecipitation analysis showed that PDK1 and hBVR interact through hBVR's PDK1 binding (161)RFGFPAFS motif and formation of the PDK1/hBVR/Akt1 complex. sihBVR blocked complex formation. Findings identify hBVR as a previously unknown coactivator of Akt1 and as a key mediator of Akt1/GSK3 pathway, as well as define a key role for hBVR in Akt1 activation by PDK1.-Miralem, T., Lerner-Marmarosh, N., Gibbs, P. E. M., Jenkins, J. L., Heimiller, C., Maines, M. D. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation. © FASEB.

Entities:  

Keywords:  Akt/hBVR/GSK3 axis; activation of hBVR; bilirubin; heme oxygenase 1

Mesh:

Substances:

Year:  2016        PMID: 27166089      PMCID: PMC4970609          DOI: 10.1096/fj.201600330RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  92 in total

Review 1.  Glycogen synthase kinase-3: properties, functions, and regulation.

Authors:  A Ali; K P Hoeflich; J R Woodgett
Journal:  Chem Rev       Date:  2001-08       Impact factor: 60.622

Review 2.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

3.  Human biliverdin reductase is autophosphorylated, and phosphorylation is required for bilirubin formation.

Authors:  M Salim; B A Brown-Kipphut; M D Maines
Journal:  J Biol Chem       Date:  2001-01-17       Impact factor: 5.157

Review 4.  The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions.

Authors:  Seunghee Yoon; Rony Seger
Journal:  Growth Factors       Date:  2006-03       Impact factor: 2.511

5.  Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible.

Authors:  M D Maines; G M Trakshel; R K Kutty
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

6.  Transcriptional control of rat heme oxygenase by heat shock.

Authors:  S Shibahara; R M Müller; H Taguchi
Journal:  J Biol Chem       Date:  1987-09-25       Impact factor: 5.157

7.  Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.

Authors:  K P Hoeflich; J Luo; E A Rubie; M S Tsao; O Jin; J R Woodgett
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

8.  Crystal structure of a biliverdin IXalpha reductase enzyme-cofactor complex.

Authors:  Frank G Whitby; John D Phillips; Christopher P Hill; William McCoubrey; Mahin D Maines
Journal:  J Mol Biol       Date:  2002-06-21       Impact factor: 5.469

9.  Biliverdin reductase: more than a namesake - the reductase, its Peptide fragments, and biliverdin regulate activity of the three classes of protein kinase C.

Authors:  Peter E M Gibbs; Cicerone Tudor; Mahin D Maines
Journal:  Front Pharmacol       Date:  2012-03-13       Impact factor: 5.810

10.  Biliverdin modulates the expression of C5aR in response to endotoxin in part via mTOR signaling.

Authors:  Kavita Bisht; Barbara Wegiel; Jens Tampe; Oliver Neubauer; Karl-Heinz Wagner; Leo E Otterbein; Andrew C Bulmer
Journal:  Biochem Biophys Res Commun       Date:  2014-05-09       Impact factor: 3.575

View more
  14 in total

1.  Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α.

Authors:  Terry D Hinds; Katherine A Burns; Peter A Hosick; Lucien McBeth; Andrea Nestor-Kalinoski; Heather A Drummond; Abdulhadi A AlAmodi; Michael W Hankins; John P Vanden Heuvel; David E Stec
Journal:  J Biol Chem       Date:  2016-10-10       Impact factor: 5.157

Review 2.  Research update on the anticancer effects of buparlisib.

Authors:  Jinshan Xing; Jun Yang; Yingjiang Gu; Jingyan Yi
Journal:  Oncol Lett       Date:  2021-02-09       Impact factor: 2.967

Review 3.  Biliverdin reductase and bilirubin in hepatic disease.

Authors:  Lauren Weaver; Abdul-Rizaq Hamoud; David E Stec; Terry D Hinds
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-01       Impact factor: 4.052

4.  Hypoglycaemic effects of glimepiride in sulfonylurea receptor 1 deficient rat.

Authors:  Xiaojun Zhou; Rui Zhang; Zhiwei Zou; Xue Shen; Tianyue Xie; Chunmei Xu; Jianjun Dong; Lin Liao
Journal:  Br J Pharmacol       Date:  2018-12-26       Impact factor: 8.739

Review 5.  Bilirubin Safeguards Cardiorenal and Metabolic Diseases: a Protective Role in Health.

Authors:  Terry D Hinds; David E Stec
Journal:  Curr Hypertens Rep       Date:  2019-10-10       Impact factor: 5.369

6.  Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway.

Authors:  Kavita Bisht; Giacomo Canesin; Tasneem Cheytan; Mailin Li; Zsuzsanna Nemeth; Eva Csizmadia; Trent M Woodruff; David E Stec; Andrew C Bulmer; Leo E Otterbein; Barbara Wegiel
Journal:  J Immunol       Date:  2019-04-05       Impact factor: 5.422

7.  Single-molecule studies reveal regulatory interactions between master kinases PDK1, AKT1, and PKC.

Authors:  Moshe T Gordon; Brian P Ziemba; Joseph J Falke
Journal:  Biophys J       Date:  2021-10-19       Impact factor: 4.033

Review 8.  Bilirubin, a Cardiometabolic Signaling Molecule.

Authors:  Terry D Hinds; David E Stec
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

Review 9.  Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.

Authors:  Mara Dierssen; Marta Fructuoso; María Martínez de Lagrán; Marzia Perluigi; Eugenio Barone
Journal:  Front Neurosci       Date:  2020-07-08       Impact factor: 4.677

Review 10.  Heme-Derived Metabolic Signals Dictate Immune Responses.

Authors:  Giacomo Canesin; Seyed M Hejazi; Kenneth D Swanson; Barbara Wegiel
Journal:  Front Immunol       Date:  2020-01-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.